Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lakhani

Showing results (191-200 of 311) with videos related to

Pageof 32
Sort By:
Breast Cancer Research and Treatment|June 22, 2012
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progressionAna Cristina Vargas, Amy E McCart Reed, Nic Waddell, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2006
The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?Sunil R Lakhani, Werner Audretsch, Anne-Marie Cleton-Jensen, et al.
Histopathology|July 20, 2024
Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breastClarissa Jing Wen Wong, Nur Diyana Md Nasir, Valerie Cui Yun Koh, et al.
The American Journal of Surgical Pathology|May 18, 2005
Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysisPeter T Simpson, Theo Gale, Jorge S Reis-Filho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab InvestigatorsAmanda B Spurdle, Sunil R Lakhani, Sue Healey, et al.
Therapeutic Advances in Medical Oncology|October 5, 2020
Clinicopathologic significance of nuclear HER4 and phospho-YAP(S<sup>127</sup>) in human breast cancers and matching brain metastasesPriyakshi Kalita-de Croft, Malcolm Lim, Haarika Chittoory, et al.
Histopathology|May 8, 2024
Dataset for reporting of the invasive carcinoma of the breast: recommendations from the International Collaboration on Cancer Reporting (ICCR)Ian Ellis, Fleur Webster, Kimberly H Allison, et al.
Human Mutation|March 12, 2011
Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundaryPhillip J Whiley, Lucia Guidugli, Logan C Walker, et al.
Breast Cancer Research and Treatment|March 28, 2025
Improved breast cancer diagnosis using a CA15-3 capture antibody-lectin sandwich assayS Nikseresht, L K Shewell, C J Day, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 9, 2013
Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitorFares Al-Ejeh, Wei Shi, Mariska Miranda, et al.
Pageof 32

Showing results (191-200 of 311) with videos related to

Sort By:
Pageof 32
Breast Cancer Research and Treatment|June 22, 2012
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progressionAna Cristina Vargas, Amy E McCart Reed, Nic Waddell, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2006
The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?Sunil R Lakhani, Werner Audretsch, Anne-Marie Cleton-Jensen, et al.
Histopathology|July 20, 2024
Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breastClarissa Jing Wen Wong, Nur Diyana Md Nasir, Valerie Cui Yun Koh, et al.
The American Journal of Surgical Pathology|May 18, 2005
Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysisPeter T Simpson, Theo Gale, Jorge S Reis-Filho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab InvestigatorsAmanda B Spurdle, Sunil R Lakhani, Sue Healey, et al.
Therapeutic Advances in Medical Oncology|October 5, 2020
Clinicopathologic significance of nuclear HER4 and phospho-YAP(S<sup>127</sup>) in human breast cancers and matching brain metastasesPriyakshi Kalita-de Croft, Malcolm Lim, Haarika Chittoory, et al.
Histopathology|May 8, 2024
Dataset for reporting of the invasive carcinoma of the breast: recommendations from the International Collaboration on Cancer Reporting (ICCR)Ian Ellis, Fleur Webster, Kimberly H Allison, et al.
Human Mutation|March 12, 2011
Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundaryPhillip J Whiley, Lucia Guidugli, Logan C Walker, et al.
Breast Cancer Research and Treatment|March 28, 2025
Improved breast cancer diagnosis using a CA15-3 capture antibody-lectin sandwich assayS Nikseresht, L K Shewell, C J Day, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 9, 2013
Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitorFares Al-Ejeh, Wei Shi, Mariska Miranda, et al.
Pageof 32